We serve Chemical Name:5-[(2R)-2-[2-(2-Ethoxyphenoxy)Ethylamino]Propyl]-2-Methoxybenzenesulfonamide Hydrochloride CAS:106138-88-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-[(2R)-2-[2-(2-Ethoxyphenoxy)Ethylamino]Propyl]-2-Methoxybenzenesulfonamide Hydrochloride
CAS.NO:106138-88-9
Synonyms:5-[(2R)-2-[2-(2-Ethoxyphenoxy)Ethylamino]Propyl]-2-Methoxybenzenesulfonamide Hydrochloride;Tamsulosin Impurity 7
Molecular Formula:C20H28N2O5S
Molecular Weight:408.51200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:595.5ºC at 760mmHg
Density:1.191g/cm3
Index of Refraction:1.553
PSA:108.26000
Exact Mass:408.17200
LogP:4.51290
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-[(2R)-2-[2-(2-Ethoxyphenoxy)Ethylamino]Propyl]-2-Methoxybenzenesulfonamide Hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Tamsulosin Impurity 7 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tamsulosin Impurity 7 Use and application,5-[(2R)-2-[2-(2-Ethoxyphenoxy)Ethylamino]Propyl]-2-Methoxybenzenesulfonamide Hydrochloride technical grade,usp/ep/jp grade.
Related News: Lonza’s Nansha site is fully integrated within the company’s global manufacturing network. Scientists and engineers based in Nansha focus on API development and manufacturing for customers around the globe. rel-methyl (1R,2S,4S)-2-(4-bromobenzoyl)-4-(4-bromophenyl)-4-hydroxy-6-oxocyclohexane-1-carboxylate manufacturers “The most important thing to be considered while determining a CDMO competency is their technical knowledge along with adequate expertise to accomplish the drug development till commercial scaling. 1-amino-3-[5-(3-amino-2-hydroxypropoxy)pentoxy]propan-2-ol suppliers MG is a “serious, lifelong disease with life-threatening manifestations, and most patients do not achieve treatment goals with conventional therapy,” the report said. 2-(3-Fluorophenyl)-4-methyl-3-(4-(methylsulfonyl)-phenyl)-2-(Z)-penten-1,4-diol vendor & factory.